These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 1820927)

  • 1. Controlled delivery of oestradiol-17-b from silastic implants: in vitro and in vivo evaluation.
    O'Sullivan M; Clancy JM; Roche JF; Corrigan OI
    Eur J Drug Metab Pharmacokinet; 1991; Spec No 3():478-82. PubMed ID: 1820927
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Silastic implants for delivery of oestradiol to mice.
    Cohen PE; Milligan SR
    J Reprod Fertil; 1993 Sep; 99(1):219-23. PubMed ID: 8283441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Release rate of testosterone and estrogens from polydimethylsiloxane implants for extended periods in vivo compared with loss in vitro.
    Greene WA; Foote RH
    Int J Fertil; 1978; 23(2):128-32. PubMed ID: 30722
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and pharmacokinetics of intravitreal 2-methoxyestradiol implants in normal rabbit and pharmacodynamics in a rat model of choroidal neovascularization.
    Robinson MR; Baffi J; Yuan P; Sung C; Byrnes G; Cox TA; Csaky KG
    Exp Eye Res; 2002 Feb; 74(2):309-17. PubMed ID: 11950241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Levodopa delivery from controlled-release polymer matrix: delivery of more than 600 days in vitro and 225 days of elevated plasma levels after subcutaneous implantation in rats.
    Sabel BA; Dominiak P; Häuser W; During MJ; Freese A
    J Pharmacol Exp Ther; 1990 Nov; 255(2):914-22. PubMed ID: 2243358
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro and in vivo characterization of a novel biocompatible polymer-lipid implant system for the sustained delivery of paclitaxel.
    Ho EA; Vassileva V; Allen C; Piquette-Miller M
    J Control Release; 2005 May; 104(1):181-91. PubMed ID: 15866344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Controlled release rate of a lipophilic drug (BCNU) from a refillable silicone rubber device.
    Ueno N; Refojo MF; Liu LH
    J Biomed Mater Res; 1982 Sep; 16(5):669-77. PubMed ID: 7130219
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oestradiol-17beta responsiveness, plasma LH profiles, pituitary LH and FSH concentrations in long-term ovariectomised Holstein cows at 24 h, 48 h and 21 days following treatment with an absorbable GnRH agonist implant.
    Padula AM; Macmillan KL
    Anim Reprod Sci; 2005 Jan; 85(1-2):27-39. PubMed ID: 15556306
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An absorbable local anesthetic matrix provides several days of functional sciatic nerve blockade.
    Wang CF; Djalali AG; Gandhi A; Knaack D; De Girolami U; Strichartz G; Gerner P
    Anesth Analg; 2009 Mar; 108(3):1027-33. PubMed ID: 19224820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro and in vivo evaluation of praziquantel loaded implants based on PEG/PCL blends.
    Cheng L; Lei L; Guo S
    Int J Pharm; 2010 Mar; 387(1-2):129-38. PubMed ID: 20005928
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro characterization of secretion rates from silastic micropellets containing estradiol.
    Elsaesser F; Hayashi S; Parvizi N; Ellendorff F
    Steroids; 1989 Aug; 54(2):159-68. PubMed ID: 2588295
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Controlled diffusional release of dispersed solute drugs from biodegradable implants of various geometries.
    Collins R; Paul Z; Reynolds DB; Short RF; Wasuwanich S
    Biomed Sci Instrum; 1997; 33():137-42. PubMed ID: 9731349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Order of magnitude differences between methods for maintaining physiological 17beta-oestradiol concentrations in ovariectomized rats.
    Ström JO; Theodorsson E; Theodorsson A
    Scand J Clin Lab Invest; 2008; 68(8):814-22. PubMed ID: 18821130
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The relationship between functional sciatic nerve block duration and the rate of release of lidocaine from a controlled-release matrix.
    Gerner P; Wang CF; Lee BS; Suzuki S; Degirolami U; Gandhi A; Knaack D; Strichartz G
    Anesth Analg; 2010 Jul; 111(1):221-9. PubMed ID: 20522702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention of bone loss by percutaneous estradiol implants in ovariectomized rats.
    Yamamura K; Iwata H; Osada T; Yano K; Yotsuyanagi T; Nabeshima T
    J Biomed Mater Res; 1995 Oct; 29(10):1249-53. PubMed ID: 8557727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of the fibrous capsule in the function of implanted drug-polymer sustained release systems.
    Anderson JM; Niven H; Pelagalli J; Olanoff LS; Jones RD
    J Biomed Mater Res; 1981 Nov; 15(6):889-902. PubMed ID: 7309770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polycaprolactone-block-poly(ethylene oxide) micelles: a nanodelivery system for 17beta-estradiol.
    Lim Soo P; Lovric J; Davidson P; Maysinger D; Eisenberg A
    Mol Pharm; 2005; 2(6):519-27. PubMed ID: 16323959
    [TBL] [Abstract][Full Text] [Related]  

  • 18. On the effects of oestrogen in the male. Some effects of different oestrogenic substances in rats and men with prostatic carcinoma.
    Daehlin L
    Scand J Urol Nephrol Suppl; 1985; 91():1-44. PubMed ID: 3868029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hydrotropic agents for study of in vitro paclitaxel release from polymeric micelles.
    Cho YW; Lee J; Lee SC; Huh KM; Park K
    J Control Release; 2004 Jun; 97(2):249-57. PubMed ID: 15196752
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Controlled drug release from an ocular implant: an evaluation using dynamic three-dimensional magnetic resonance imaging.
    Kim H; Robinson MR; Lizak MJ; Tansey G; Lutz RJ; Yuan P; Wang NS; Csaky KG
    Invest Ophthalmol Vis Sci; 2004 Aug; 45(8):2722-31. PubMed ID: 15277497
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.